Virtus Fund Advisers’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $981K | Buy |
+11,479
| New | +$981K | 0.01% | 291 |
|
|
2017
Q1 | – | Sell |
-8,409
| Closed | -$533K | – | 541 |
|
|
2016
Q4 | $533K | Hold |
8,409
| – | – | ﹤0.01% | 327 |
|
|
2016
Q3 | $535K | Sell |
8,409
-2,041
| -20% | -$130K | ﹤0.01% | 321 |
|
|
2016
Q2 | $796K | Sell |
10,450
-3,826
| -27% | -$291K | 0.01% | 288 |
|
|
2016
Q1 | $954K | Sell |
14,276
-3,083
| -18% | -$206K | 0.01% | 284 |
|
|
2015
Q4 | $1.17M | Sell |
17,359
-181
| -1% | -$12.2K | 0.01% | 275 |
|
|
2015
Q3 | $937K | Sell |
17,540
-26,038
| -60% | -$1.39M | 0.01% | 284 |
|
|
2015
Q2 | $2.74M | Sell |
43,578
-607
| -1% | -$38.2K | 0.02% | 282 |
|
|
2015
Q1 | $2.13M | Sell |
44,185
-11,901
| -21% | -$572K | 0.02% | 315 |
|
|
2014
Q4 | $1.86M | Buy |
56,086
+25,647
| +84% | +$851K | 0.01% | 338 |
|
|
2014
Q3 | $892K | Sell |
30,439
-2,621
| -8% | -$76.8K | 0.01% | 401 |
|
|
2014
Q2 | $1.29M | Buy |
+33,060
| New | +$1.29M | 0.01% | 415 |
|